More Is Needed for Immunotherapy in Lung CancerByFred R. Hirsch, MD, PhDJuly 31st 2019From long-term data to additional clinical trials, more is needed to better understand immunotherapy in lung cancer.
Dr. Fred R. Hirsch on Unmet Needs in Lung CancerByFred R. Hirsch, MD, PhDAugust 21st 2015Fred R. Hirsch, MD, PhD, professor of medicine, professor in pathology, University of Colorado, CEO, IASLC, discusses unmet needs in the treatment of lung cancer.